ExclusiveIs Hope for Alzheimer’s and Rare Childhood Disease to Restore Lost Brain Molecule?｜Vital Signs

Children born with the rare, genetic disease—RCDP—usually die within a few years due to loss of a vital brain molecule, plasmalogen, also found low in those with Alzheimer’s disease. Could restoring plasmalogens revive health for both conditions?

In 2007, Dr. Dayan Goodenowe discovered a single molecule much lower than normal in the blood of people with Alzheimer’s Disease. Using his own technology he identified that molecule as plasmalogen – a key brain molecule made in sufficient supply in the cells of a healthy, functioning body. Was loss of plasmalogen causing Alzheimer’s disease? What would happen if plasmalogen could be restored? The challenge was set.

Dr. Goodenowe has since invented a novel plasmalogen supplement being trialed by Alzhimer’s sufferers across America. But on the opposite end of the life spectrum, two children with a rare (1 in every 100,000 births) disease – RCDP* – display the most compelling results of this treatment.

How has life changed for six-year-old Thatcher and three-year-old Nova since having this lost, vital nutrient, restored? What signs are there that restoring plasmalogens could benefit Alzheimer’s sufferers?

*RCDP – rhizomelic chondrodysplasia punctata

====================
Vital Signs’ host, guests, and contributors offer general information on improving health and wellness. This is not intended as diagnosis or medical advice. You should consult your medical doctor or holistic doctor before enacting any suggested strategies for health and wellness improvement, including those in relation to preventing or treating specific diseases featured on this program.